Skip to main content
. 2012 Jun;1(2):78–88. doi: 10.3978/j.issn.2223-4683.2012.05.06

Table 1. Genes with known association with TGF-β that have DNA hypermethylation in prostate cancer.

Name Function Reference
1. TBRI TGF-β receptor type I (30,31)
2. TBRIITGF-β TGF-β receptor type II (31,32)
3. cdh13herin Adhesion molecule, tumor suppressor (33,34)
4. TTP (tristetrapolin) Loss of TTP stabilizes c-Myc mRNA (35)
5. TGFBI (Betaig-h3) TGF-β induced gene (36-38)
6. IGFBP3 IGF binding protein 3 (39,40)
7. beta 4-integrin Promotes focal adhesion (34)
8. MAL Promotes cell differentiation (41,42)
9. SLIT2 Negative regulation of migration (36,41,43)
10. Bcl2 Involved in apoptosis (40,41)
11. Caspase 8 Pro-apoptotic gene (44)
12. EPHA7 Tumor suppressor in prostate cancer (45-47)
13. BTG3 Tumor suppressor (48,49)
14. PTGS2 Pro-inflammatory enzyme (50-52)
15. HIN1 (or SCGB3A1) Tumor suppressor (41,53)
16. RASSF1A Tumor suppressor gene (54-56)
17. CHD13 Adhesion molecule (41,57,58)
18. p15, p16, p21, p27, p57 Cell cycle regulators (57,59-61)
19. RASSF1A Pro-apoptotic, negative Ras effector (41,62)
20. TWIST1 Suppressor of E-cadherin (41)
21. FHIT Induces apoptosis though Bak (63,64)
22. SOCS3 Negative regulator of cytokine (65,66)
23. TIMP-2, TIMP-3 Inhibitors of metalloproteinase (67-69)
24. PITX2 Activator of cyclin D2 (41,70-72)
25. DcR1, DcR2 Fail to induced apoptosis through TRAIL (73,74)
26. GLIPR1 (or RTVP-1) p53 target gene (75,76)
27. MGMT DNA repair gene (77-81)
28. DKK3 (SFRP1) Wnt antagonist (82,83)
29. RUNX3 Tumor suppressor (84-86)
30. CAV-1 Tumor suppressor (87,88)
31. Clusterin Apoptotic protein (89-91)
32. TFPI2 (PP5, MSPI) A potent inhibitor of matrix-metalloproteinases (92,93)
33. SOX7 Suppressor of β-catenin (94,95)
34. SLC5A8 Tumor suppressor (96,97)
35. SLC18A2 (or VMAT2) Affects apoptosis and migration (98,99)
36. LPL Tumor suppressor gene (100,101)
37. HRK (or ATF-2) Proapoptosis (102,103)
38. INHBB Inhibin betaB (104,105)
39. ID4 Inhibitor of DNA binding (41,106-108)
40. FYN Promotes proliferation and motility (109,110)
41. HPP1 (TMEFF2) TGF-β signal pathway (73,84)
42. RRAD Ras-related GTPases (111,112)
43. DRM/Gremlin Down-regulated in Mos-transformed cells (73,84)